Insider buying
~$63K4,068 sh @ $15.38
Traded Nov 12 · filed 5 days later
Since the trade −12.5% · S&P 500 −8.9% · to Nov 20
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 35 min ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
Traded Nov 12 · filed 5 days later
Since the trade −12.5% · S&P 500 −8.9% · to Nov 20
Lately at Equipmentshare.Com: the stock rose 18% in one session on Nov 11 with press coverage; it reported its results on Nov 9; the stock is down 20% in 30 days.
Insider buying
5 insiders in a week, 2nd time since 2006Traded Nov 16 · filed 1 day later
Since the trade −18.4% · S&P 500 −6.8% · to Nov 20
Bought 84% below the 52-week high, RSI 29, 73% under its 200-day average, 67 points behind the S&P 500 over 3 months
A Perspective Therapeutics director paid $14K out of pocket for Perspective Therapeutics shares. 4 other people at Perspective Therapeutics bought some too, in the same month. Shares held went up 100% with this purchase.
Lately at Perspective Therapeutics: the stock fell 29% in one session on Oct 23 around a company release; it reported its results on Nov 9; the stock is down 67% in 30 days.
Insider buying
3 insiders in a week, a first since 2006Traded Nov 16 · filed 1 day later
Since the trade −6.9% · S&P 500 −6.8% · to Nov 20
Bought 45% below the 52-week high, RSI 61, 16% under its 200-day average, 36 points behind the S&P 500 over 3 months
A Cvd Equipment director paid $170K out of pocket for Cvd Equipment shares. 2 other people at Cvd Equipment bought some too, in the same month.
Lately at Cvd Equipment: the stock rose 14% in one session on Nov 13 with press coverage; it reported its results on Nov 5; the stock is up 13% in 30 days.
Insider buying
Traded Nov 16 · filed 1 day later
Since the trade −7.6% · S&P 500 −6.8% · to Nov 20
Bought 27% below the 52-week high, RSI 38, 15% under its 200-day average, 18 points behind the S&P 500 over 3 months
An Eaton director paid $102K out of pocket for Eaton shares. 1 other person at Eaton bought some too, in the same month. Shares held went up 16% with this purchase.
Lately at Eaton Corporation: it reported its results on Nov 3; the stock is down 21% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 13 · filed 4 days later
Since the trade +1.4% · S&P 500 −8.6% · to Nov 20
Bought within 1% of the 52-week high, RSI 73, 31% above its 200-day average, 31 points ahead of the S&P 500 over 3 months
An Upbound director paid $49K out of pocket for Upbound shares. 9 other people at Upbound bought some too, in the same month. It was the first purchase in over a year.
Lately at Upbound Group, Inc.: the stock rose 10% in one session on Nov 2 with press coverage; it reported its results on Oct 29; the stock is up 57% in 30 days.
Insider buying
Traded Nov 16 · filed 1 day later
Since the trade −11.8% · S&P 500 −6.8% · to Nov 20
A Davion Healthcare director paid $26K out of pocket for Davion Healthcare shares. 1 other person at Davion Healthcare bought some too, in the same month. It was the first purchase in over a year.
Lately at Davion Healthcare: the stock is 92% below its 12-month high.
Insider buying
Traded Nov 17 · filed the same day
Since the trade −3.9% · S&P 500 −5.8% · to Nov 20
Bought 22% below the 52-week high, RSI 33, 10% under its 200-day average
Bladex's Chief Legal Officer paid $125K out of pocket for Bladex shares. 1 other person at Bladex bought some too, in the same month. Shares held went up 17% with this purchase.
Lately at Bladex: the stock is down 15% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First insider buy since Mar 2025Traded Nov 16 · filed 1 day later
Since the trade −10.3% · S&P 500 −6.8% · to Nov 20
Openworld's President, Precision Logistics paid $20K out of pocket for Openworld shares. 1 other person at Openworld bought some too, in the same month. It was the first purchase in 20 months.
Lately at Openworld: it reported its results on Nov 12; the stock is down 75% in 30 days.
Insider buying
5 insiders in a week, 2nd time since 2012Traded Nov 13 · filed 4 days later
Since the trade −16.2% · S&P 500 −8.6% · to Nov 20
Bought 70% below the 52-week high, RSI 52, 37% under its 200-day average, 24 points behind the S&P 500 over 3 months
The CEO of Inspiremd paid $30K out of pocket for Inspiremd shares. 4 other people at Inspiremd bought some too, in the same month. It was the first purchase in 6 months.
Lately at Inspiremd: it signed an important agreement on Nov 16; the stock is up 21% in 30 days; insiders made 6 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First buy since 2022Traded Nov 16 · filed 1 day later
Since the trade −11.6% · S&P 500 −6.8% · to Nov 20
Bought 65% below the 52-week high, RSI 38, 39% under its 200-day average, 28 points behind the S&P 500 over 3 months
The CFO of Castellum paid $22K out of pocket for Castellum shares. 1 other person at Castellum bought some too, in the same month. Shares held went up 278% with this purchase.
Lately at Castellum: it reported its results on Nov 6; the stock is down 37% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
First buy since 2023Traded Nov 17 · filed the same day
Since the trade −0.1% · S&P 500 −5.8% · to Nov 20
Bought at the 52-week low, RSI 32, 10% under its 200-day average
An Umh Properties director paid $42K out of pocket for Umh Properties shares. 2 other people at Umh Properties bought some too, in the same month. It was the first purchase in over a year.
Lately at Umh Properties: it reported its results on Nov 2; the stock is down 7% in 30 days; insiders made 4 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Bought outside the usual windowTraded Nov 11 · filed 6 days later
Since the trade −35.2% · S&P 500 −9.2% · to Nov 20
Bought 52% below the 52-week high, RSI 62, 11% above its 200-day average, 18 points behind the S&P 500 over 3 months
A major shareholder of Claritev paid $390K out of pocket for Claritev shares. 1 other person at Claritev bought some too, in the same month.
Lately at Claritev: the stock rose 19% in one session on Nov 10 with press coverage; it changed a top executive or board member on Oct 15; the stock is down 21% in 30 days.
Insider buying
First insider buy since Jun 2022Traded Nov 13 · filed 4 days later
Since the trade −0.6% · S&P 500 −8.6% · to Nov 20
Bought within 3% of the 52-week low, RSI 34, 37% under its 200-day average, 33 points behind the S&P 500 over 3 months
The CEO of Brightspire Capital paid $251K out of pocket for Brightspire Capital shares. Shares held went up 5% with this purchase.
Lately at Brightspire Capital: it reported its results on Oct 27; the stock is down 12% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 13 · filed 4 days later
Since the trade +11.0% · S&P 500 −8.6% · to Nov 20
Bought 66% below the 52-week high, RSI 37, 28% under its 200-day average, 26 points behind the S&P 500 over 3 months
The CEO of Maia Biotechnology paid $60K out of pocket for Maia Biotechnology shares. 1 other person at Maia Biotechnology bought some too, in the same month. Shares held went up 6% with this purchase.
Lately at Maia Biotechnology: the stock is 62% below its 12-month high; insiders made 10 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Traded Nov 16 · filed 1 day later
Since the trade +15.5% · S&P 500 −6.8% · to Nov 20
Bought at the 52-week low, RSI 24, 72% under its 200-day average, 64 points behind the S&P 500 over 3 months
An Opendoor Technologies director paid $117K out of pocket for Opendoor Technologies shares. Shares held went up 22% with this purchase.
Lately at Opendoor Technologies: it reported its results on Nov 5; the stock is down 33% in 30 days; insiders made 2 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Their first buy on recordTraded Nov 13 · filed 4 days later
Since the trade +40.8% · S&P 500 −8.6% · to Nov 20
Deep Fission's Chief Technology Officer paid $32K out of pocket for Deep Fission shares. 4 other people at Deep Fission bought some too, in the same month. It was the first purchase in over a year.
Lately at Deep Fission: the stock fell 32% in one session on Nov 5 with press coverage; the stock is up 10% in 30 days; insiders made 3 purchases ($10K+) and no large sale ($250K+, not pre-arranged) in 90 days.
Insider buying
Bought outside the usual windowTraded Nov 17 · filed the same day
Since the trade −4.5% · S&P 500 −5.8% · to Nov 20
Bought within 1% of the 52-week low, RSI 30, 64% under its 200-day average, 58 points behind the S&P 500 over 3 months
The CEO of Ss Innovations International paid $300K out of pocket for Ss Innovations International shares. It was the first purchase in 8 months.
Lately at Ss Innovations International: the stock fell 11% in one session on Nov 9; it changed a top executive or board member on Nov 17; the stock is down 47% in 30 days.
Insider buying
3 insiders in a week, 5th time since 2019Traded Nov 13 · filed 4 days later
Since the trade −3.5% · S&P 500 −8.6% · to Nov 20
Bought 46% below the 52-week high, RSI 37, 22% under its 200-day average, 31 points behind the S&P 500 over 3 months
A Target Hospitality director paid $46K out of pocket for Target Hospitality shares. 2 other people at Target Hospitality bought some too, in the same month. Shares held went up 6% with this purchase.
Lately at Target Hospitality: the stock rose 15% in one session on Nov 11 with press coverage; it reported its results on Nov 9; the stock is down 29% in 30 days.
Traded Nov 13, 2026 · largest single transaction ~$50K
Lately at Magnachip Semiconductor: the stock rose 17% in one session on Nov 11 with press coverage; it reported its results on Nov 4; the stock is down 19% in 30 days.
Nov 13, 2026~$50K · 20K sh @ $2.51
DetailsOfficial recordNov 13, 2026~$50K · 20K sh @ $2.50
DetailsOfficial record